Regenerative medicine using human placental tissue products
BioTissue manufactures medical products from human amniotic and umbilical cord tissues for wound care and regenerative applications. The hiring mix is heavily sales-driven (15 of 34 open roles) alongside manufacturing and operations roles, reflecting a commercial-stage company scaling field coverage and production capacity. Active projects center on account penetration, territory planning, and regulatory compliance (stability/degradation studies, QMS monitoring), while pain points cluster around product quality assurance, tissue utilization efficiency, and field productivity — typical constraints for a biologics manufacturer moving through scale-up.
BioTissue develops medical products derived from human placental tissues for regenerative healing applications. The company operates in the biotechnology and medical device space, serving clinicians and patients across multiple therapeutic areas. Infrastructure is anchored in Microsoft Azure (VMs, Logic Apps, Monitor) and Salesforce-based CRM and ERP systems (Dynamics 365, NetSuite, Infor, Sage X3), with statistical and operational analytics via SPSS, Minitab, and Power BI. The organization spans sales, manufacturing, operations, healthcare affairs, and finance functions, with active hiring concentrated in field sales and production roles. Based in Miami, Florida, the company operates across the United States.
BioTissue manufactures medical products derived from human amniotic and umbilical cord tissues, pioneered since 1997, with documented use in more than 680,000 patient treatments.
BioTissue uses Salesforce, Dynamics 365, NetSuite, and Infor for CRM and ERP; Microsoft Azure for cloud infrastructure; and SPSS and Minitab for statistical analysis and quality monitoring.
Other companies in the same industry, closest in size
BioTissue's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.